TY  - JOUR

T1  - Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, investigational drug branch for breast cancer and the new drug development group study

JO  - J CLIN ONCOL

PY  - 2004/07/01

AU  - Bottomley A

AU  - Biganzoli L

AU  - Cufer T

AU  - Coleman RE

AU  - Coens C

AU  - Efficace F

AU  - Calvert HA

AU  - Gamucci T

AU  - Twelves C

AU  - Fargeot P

AU  - Piccart M

ED  - 

DO  - DOI: 10.1200/JCO.2004.02.037

VL  - 22

IS  - 13

SP  - 2576

EP  - 2586

Y2  - 2025/10/10

ER  -